Stocks · News reference

Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.

Jul 23, 2026, 12:04 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 20, 2026, 12:06 PMBenzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.
Read original at benzinga
BIVI CIRC EDSA HYPD IVF
SEC EDGARAug 7, 2026, 8:00 PMSEC EDGAR
8-K filing — Niki BioSolutions, Inc. (NIKI)
Filed: 2026-08-07 AccNo: 0001213900-26-086639 Size: 232 KB Item 8.01: Other Events
Read original at edgar
NIKI
BenzingaJul 23, 2026, 12:02 PMBenzinga Newsdesk
Niki BioSolutions’ DiamiR Biosciences Agrees To Provide Progressive Medical Research With Apolipoprotein E Genotyping Services In Support Of Ongoing Clinical And Translational Research Programs
Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research ProgramsNEW HAVEN, CT and PRINCETON, NJ, July 23, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc., a clinical-stage life
Read original at benzinga
NIKI